The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant

D Tian, Y Sun, H Xu, Q Ye - Journal of medical virology, 2022 - Wiley Online Library
Recently, the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Omicron
variant (B. 1.1. 529) was first identified in Botswana in November 2021. It was first reported …

Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms

B Silva Andrade, S Siqueira, WR de Assis Soares… - Viruses, 2021 - mdpi.com
The COVID-19 pandemic has infected millions worldwide, leaving a global burden for long-
term care of COVID-19 survivors. It is thus imperative to study post-COVID (ie, short-term) …

The global epidemic of the SARS-CoV-2 delta variant, key spike mutations and immune escape

D Tian, Y Sun, J Zhou, Q Ye - Frontiers in immunology, 2021 - frontiersin.org
During the COVID-19 pandemic, SARS-CoV-2 variants have emerged and spread
worldwide. The Delta (B. 1.617. 2) variant was first reported in India in October 2020 and …

The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity

Y Zhou, H Zhi, Y Teng - Journal of medical virology, 2023 - Wiley Online Library
As of November 2021, several SARS‐CoV‐2 variants appeared and became dominant
epidemic strains in many countries, including five variants of concern (VOCs) Alpha, Beta …

The global epidemic of SARS‐CoV‐2 variants and their mutational immune escape

D Tian, YH Sun, JM Zhou, Q Ye - Journal of medical virology, 2022 - Wiley Online Library
During the COVID‐19 pandemic, genetic variants of SARS‐CoV‐2 have been emerging and
spreading around the world. Several SARS‐CoV‐2 endemic variants were found in United …

Gastrointestinal manifestations in COVID-19

JC Kariyawasam, U Jayarajah, R Riza… - Transactions of The …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19), a respiratory viral infection, has affected
more than 78 million individuals worldwide as of the end of December 2020. Previous …

SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip

Y Guo, R Luo, Y Wang, P Deng, T Song, M Zhang… - Science bulletin, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic. Clinical evidence …

[HTML][HTML] Cellular immune response to COVID-19 and potential immune modulators

X Zhou, Q Ye - Frontiers in immunology, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Droplets and contacts serve as …

Gut microbiota diversity and C-reactive protein are predictors of disease severity in COVID-19 patients

A Moreira-Rosário, C Marques, H Pinheiro… - Frontiers in …, 2021 - frontiersin.org
The risk factors for coronavirus disease 2019 (COVID-19) severity are still poorly
understood. Considering the pivotal role of the gut microbiota on host immune and …

[HTML][HTML] Challenges of SARS-CoV-2 Omicron Variant and appropriate countermeasures

W Shao, W Zhang, X Fang, D Yu, X Wang - Journal of Microbiology …, 2022 - Elsevier
Abstract The Omicron (B. 1.1. 529) variant was first reported in South Africa and rapidly
spread worldwide in early November 2021. This caused panic in various countries, so it is …